Article
Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jul 2015
Chen Yang, Shen Zuojun
Abstract excerpt
The antifolate drug methotrexate (MTX) is widely used in the treatment of various neoplastic diseases, including acute lymphoblastic leukemia (ALL). MTX significantly increases cure rates and improves patients' prognosis. Despite that it achieved remarkable clinical success, a large number of patients still suffer from treatment toxicities or side effects. Even to this date, chemotherapeutic regiments have not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
